Quantum Dot-DNA FRET Conjugates for Direct Analysis of Methylphosphonic Acid in Complex Media

Area of Science:

• Analytical Chemistry
• Biotechnology
• Nanotechnology

Background:

• Nerve agents pose significant threats due to their toxicity.
• Rapid detection methods are crucial for immediate response and safety.
• Complex matrices complicate the analysis of nerve agent metabolites.

Purpose of the Study:

• To develop a rapid, sensitive biosensor for nerve agent metabolite detection.
• To functionalize quantum dots (QDs) with aptamers for specific targeting.
• To utilize Förster resonance energy transfer (FRET) for quantitative measurement.

Main Methods:

• Functionalization of quantum dots (QDs) with oligonucleotide aptamers.
• Creation of QD-DNA bioconjugates linked to quencher molecules.
• Formation of FRET donor-acceptor pairs for methylphosphonic acid (MePA) detection.
• Measurement of QD lifetime changes upon MePA binding.

Main Results:

• A FRET-based biosensor was successfully developed.
• The biosensor achieved a MePA limit of detection of 743 nM in artificial urine.
• QD lifetime measurements correlated with MePA presence, showing signal recovery.
• The system demonstrated quantitative measurement capabilities.

Conclusions:

• The developed QD-aptamer FRET biosensor offers rapid detection of nerve agent metabolites.
• The flexible design is suitable for deployable, in-field chemical and biological agent detection.
• This technology holds promise for enhanced safety and security applications.